ImmunityBio, Inc. (IBRX)
9.85
-0.59
(-5.65%)
USD |
NASDAQ |
Mar 03, 09:57
ImmunityBio Research and Development Expense (Annual) : 216.56M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Novo Nordisk A/S | 6.838B |
| Iovance Biotherapeutics, Inc. | 300.27M |
| Krystal Biotech, Inc. | 52.32M |
| Arcellx, Inc. | 157.61M |
| Novavax, Inc. | 336.82M |